Precigen Inc. (PGEN) Misses Q3 EPS by 97c

Precigen Inc. (NASDAQ: PGEN) reported Q3 EPS of ($1.06), $0.97 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $2.92 million versus the consensus estimate of $900 thousand.

For earnings history and earnings-related data on Precigen Inc. (PGEN) click here.

You May Also Be Interested In

• Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
• Security Federal Corporation (SFDL) Declares $0.16 Quarterly Dividend; 1.5% Yield
• Target raises full-year sales forecast amid ongoing turnaround drive